Conference
Association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.
Abstract
118
Background: In men with metastatic castration resistant prostate cancer (CRPC),the association of measurable tumor responses with overall survival (OS) is unknown. We retrospectively evaluated the TAX327 phase III trial to study this relationship.
Authors
Sonpavde G; Pond GR; Berry WR; De Wit R; Eisenberger MA; Tannock I; Armstrong AJ
Volume
29
Pagination
pp. 118-118
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 1, 2011
DOI
10.1200/jco.2011.29.7_suppl.118
Conference proceedings
Journal of Clinical Oncology
Issue
7_suppl
ISSN
0732-183X